Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Atomic Spectroscopy
... CAGR of 6.9% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Testing, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$6.2 Billion by the end of ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing
... 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Breakthrough Therapy (BT) Designation
... 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$138.3 Billion by the end ... Read More
-
Artificial Intelligence (AI) in Drug Discovery
... reach US$13.5 Billion by 2030, growing at a CAGR of 26.4% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$3.0 ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Disposable Respirators
... CAGR of 4.5% over the analysis period 2024-2030. N-Series, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Breast Cancer Liquid Biopsy
... 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Reagent Kits, one of the segments analyzed in the report, is expected to record a 22.4% CAGR and reach US$819.3 Million by the ... Read More
-
FISH Probe
... CAGR of 5.9% over the analysis period 2024-2030. Q-FISH, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$638.3 Million by the end of the analysis period. ... Read More
-
Healthcare Contract Management Software
... 2030, growing at a CAGR of 19.3% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$7.1 Billion by the end ... Read More
-
Hereditary Testing
... CAGR of 6.2% over the analysis period 2024-2030. Preimplantation Genetic Diagnosis & Screening, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 Billion by the end ... Read More
-
In Vivo Contract Research Organization (CRO)
... reach US$8.0 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and ... Read More
-
IR Spectroscopy
... CAGR of 5.1% over the analysis period 2024-2030. Benchtop, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$647.6 Million by the end of the analysis period. ... Read More
-
Plant Genomics
... CAGR of 8.0% over the analysis period 2024-2030. Molecular Engineering, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.5 Billion by the end of the analysis ... Read More
-
Portable Gas Chromatographs
... at a CAGR of 6.1% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the end of the ... Read More
-
Precision Medicine
... CAGR of 8.7% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$89.0 Billion by the end of the analysis period. ... Read More
-
Preimplantation Genetic Testing
... at a CAGR of 10.1% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$794.1 Million by the end ... Read More
-
Protein Engineering
... CAGR of 14.5% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$3.3 Billion by the end of the analysis period. ... Read More
-
Tissue Engineered Skin Substitutes
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Biological, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.9 Billion by the end ... Read More
-
Non-GMO Foods
... CAGR of 3.2% over the analysis period 2024-2030. Non-GMO Cereals & Grains, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$97.1 Billion by the end of ... Read More
-
Plant Biotechnology Equipment
... at a CAGR of 14.2% over the analysis period 2024-2030. Breeding, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$25.6 Billion by the end of the ... Read More
-
Plant Breeding and CRISPR Plants
... Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2024-2030. Conventional Breeding, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$16.0 Billion ... Read More
-
Precision Medicine Software
... at a CAGR of 10.0% over the analysis period 2024-2030. On-Premise, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Protein Detection and Quantification
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.4 Billion by ... Read More
-
Protein Sequencing
... CAGR of 2.9% over the analysis period 2024-2030. Mass Spectrometry, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis ... Read More
-
Spatial Genomics and Transcriptomics
... 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$320.3 Million by the end ... Read More
Research Assistance
